{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T06:30:18Z","timestamp":1649140218545},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00399-021-00825-9","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T09:02:43Z","timestamp":1636362163000},"page":"492-499","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patientin mit einem Defibrillator zur kardialen Resynchronisationstherapie und zunehmender Herzinsuffizienzsymptomatik"],"prefix":"10.1007","volume":"32","author":[{"given":"Ralph","family":"Bosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"825_CR1","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/eurheartj\/ehw526","volume":"38","author":"J Brugada","year":"2017","unstructured":"Brugada\u00a0J, Delnoy\u00a0PP, Brachmann\u00a0J et al (2017) Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart\u00a0J 38:730\u2013738. https:\/\/doi.org\/10.1093\/eurheartj\/ehw526","journal-title":"Eur Heart J"},{"key":"825_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1161\/CIRCEP.112.973776","volume":"5","author":"A Cheng","year":"2012","unstructured":"Cheng\u00a0A, Landman\u00a0SR, Stadler\u00a0RW (2012) Reasons for loss of cardiac resynchronization therapy pacing. Circ Arrhythm Electrophysiol 5:884\u2013888. https:\/\/doi.org\/10.1161\/CIRCEP.112.973776","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"825_CR3","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1161\/CIRCULATIONAHA.110.992552","volume":"122","author":"KA Ellenbogen","year":"2010","unstructured":"Ellenbogen\u00a0KA, Gold\u00a0MR, Meyer\u00a0TE et al (2010) Primary results from the smartdelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial. Circulation 122:2660\u20132668. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.992552","journal-title":"Circulation"},{"key":"825_CR4","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/ejhf.895","volume":"19","author":"G Filippatos","year":"2017","unstructured":"Filippatos\u00a0G, Birnie\u00a0D, Gold\u00a0MR et al (2017) Rationale and design of the AdaptResponse trial: a\u00a0prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing. Eur J Heart Fail 19:950\u2013957. https:\/\/doi.org\/10.1002\/ejhf.895","journal-title":"Eur J Heart Fail"},{"key":"825_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.hrthm.2011.04.015","volume":"8","author":"DL Hayes","year":"2011","unstructured":"Hayes\u00a0DL, Boehmer\u00a0JP, Day\u00a0JD et\u00a0al (2011) Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8:1469\u20131475. https:\/\/doi.org\/10.1016\/j.hrthm.2011.04.015","journal-title":"Heart Rhythm"},{"key":"825_CR6","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jacc.2008.12.022","volume":"53","author":"GS Kamath","year":"2009","unstructured":"Kamath\u00a0GS, Cotiga\u00a0D, Koneru\u00a0JN et al (2009) The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. J\u00a0Am Coll Cardiol 53:1050\u20131055. https:\/\/doi.org\/10.1016\/j.jacc.2008.12.022","journal-title":"J Am Coll Cardiol"},{"key":"825_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jacc.2008.09.043","volume":"53","author":"BA Koplan","year":"2009","unstructured":"Koplan\u00a0BA, Kaplan\u00a0AJ, Weiner\u00a0S et al (2009) Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a\u00a0goal of 100\u202f% biventricular pacing necessary? J\u00a0Am Coll Cardiol 53:355\u2013360. https:\/\/doi.org\/10.1016\/j.jacc.2008.09.043","journal-title":"J Am Coll Cardiol"},{"key":"825_CR8","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.hrthm.2012.07.009","volume":"9","author":"DO Martin","year":"2012","unstructured":"Martin\u00a0DO, Lemke\u00a0B, Birnie\u00a0D et al (2012) Investigation of a\u00a0novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm 9:1807\u20131814.e1. https:\/\/doi.org\/10.1016\/j.hrthm.2012.07.009","journal-title":"Heart Rhythm"},{"key":"825_CR9","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ejhf.2046","volume":"22","author":"W Mullens","year":"2020","unstructured":"Mullens\u00a0W, Auricchio\u00a0A, Martens\u00a0P et\u00a0al (2020) Optimized implementation of cardiac resynchronization therapy: a\u00a0call for action for referral and optimization of care. Eur J Heart Fail 22:2349\u20132369. https:\/\/doi.org\/10.1002\/ejhf.2046","journal-title":"Eur J Heart Fail"},{"key":"825_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jacc.2008.11.024","volume":"53","author":"W Mullens","year":"2009","unstructured":"Mullens\u00a0W, Grimm\u00a0RA, Verga\u00a0T et\u00a0al (2009) Insights From a\u00a0Cardiac Resynchronization Optimization Clinic as Part of a\u00a0Heart Failure Disease Management Program. J\u00a0Am Coll Cardiol 53:765\u2013773. https:\/\/doi.org\/10.1016\/j.jacc.2008.11.024","journal-title":"J Am Coll Cardiol"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-021-00825-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-021-00825-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-021-00825-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T10:10:19Z","timestamp":1638526219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-021-00825-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["825"],"URL":"https:\/\/doi.org\/10.1007\/s00399-021-00825-9","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Bosch gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}